Clinical and angiographic risk factors for stroke and death within 30 days after carotid endarterectomy and stent-protected angioplasty: a subanalysis of the SPACE study

The Lancet Neurology

Volumn 7, Issue 3, 2008, Pages 216-222

  Stingele, Robert ^a   Berger, Jürgen ^b   Alfke, Karsten ^a   Eckstein, Hans Henning ^c   Fraedrich, Gustav ^d   Allenberg, Jens ^e   Hartmann, Marius ^e   Ringleb, Peter A ^e   Fiehler, Jens ^b  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^b UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^c TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^d UNIVERSITY OF INNSBRUCK   (Austria)

^e UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CAROTID ARTERY STENT; CAROTID ENDARTERECTOMY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY RISK; DISEASE CLASSIFICATION; FEMALE; HEART DEATH; HIGH RISK PATIENT; HUMAN; INTERMETHOD COMPARISON; INTERNAL CAROTID ARTERY OCCLUSION; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; OUTCOME ASSESSMENT; POST HOC ANALYSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; RISK FACTOR; STENT; STROKE; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ANGIOPLASTY; CAROTID ARTERY, INTERNAL; CAROTID STENOSIS; ENDARTERECTOMY, CAROTID; FEMALE; HUMANS; MALE; MIDDLE AGED; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK FACTORS; SEVERITY OF ILLNESS INDEX; STROKE; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 39149103367     PISSN: 14744422     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1474-4422(08)70024-3     Document Type: Article

References (22)

1. Bond R., Rerkasem K., and Rothwell P. Systematic review of the risks of carotid endarterectomy in relation to the clinical indication for and timing of surgery. Stroke 34 (2003) 2290-2301
2. Ouriel K., Hertzer N., Beven E., et al. Preprocedural risk stratification: identifying an appropriate population for carotid stenting. J Vasc Surg 33 (2001) 728-732
3. Ringleb P., Allenberg J., Bruckmann H., et al. 30 day results from the SPACE trial of stent-protected angioplasty versus carotid endarterectomy in symptomatic patients: a randomised non-inferiority trial. Lancet 368 (2006) 1239-1247
4. Barnett H., Taylor D., Eliasziw M., et al. Benefit of carotid endarterectomy in patients with symptomatic moderate or severe stenosis. North American Symptomatic Carotid Endarterectomy Trial Collaborators. N Engl J Med 339 (1998) 1415-1425
5. European Carotid Surgery Trialists' Collaborative Group. Randomised trial of endarterectomy for recently symptomatic carotid stenosis: final results of the MRC European Carotid Surgery Trial (ECST). Lancet 351 (1998) 1379-1387
6. Rothwell P., Warlow C., and for the European Carotid Surgery Trialists' Collaborative Group. Prediction of benefit from carotid endarterectomy in individual patients: a risk-modelling study. Lancet 353 (1999) 2105-2110
7. Royston P., Ambler G., and Sauerbrei W. The use of fractional polynomials to model continuous risk variables in epidemiology. Int J Epidemiol 28 (1999) 964-974
8. Breiman L., Friedman J., Stone C., and Olshen R. Classification and regression trees (1998), Chapman and Hall
9. Rothwell P., Slattery J., and Warlow C. Clinical and angiographic predictors of stroke and death from carotid endarterectomy: systematic review. BMJ 315 (1997) 1571-1577
10. Gaines P. The evidence for carotid stenting versus carotid endarterectomy in symptomatic patients. Eur J Radiol 60 (2006) 8-10
11. Narins C., and Illig K. Patient selection for carotid stenting versus endarterectomy: a systematic review. J Vasc Surg 44 (2006) 661-672
12. Hobson R., Howard V., Roubin G., et al. Carotid artery stenting is associated with increased complications in octogenarians: 30-day stroke and death rates in the CREST lead-in phase. J Vasc Surg 40 (2004) 1106-1111
13. Kastrup A., Groschel K., Schulz J., Nagele T., and Ernemann U. Clinical predictors of transient ischemic attack, stroke, or death within 30 days of carotid angioplasty and stenting. Stroke 36 (2005) 787-791
14. Ederle J., Featherstone R., and Brown M. Percutaneous transluminal angioplasty and stenting for carotid artery stenosis. Cochrane Database Syst Rev 4 (2007) CD000515.
15. Yadav J., Wholey M., Kuntz R., et al. Protected carotid-artery stenting versus endarterectomy in high-risk patients. N Engl J Med 351 (2004) 1493-1501
16. Goldstein L., Adams R., Alberts M., et al. Primary prevention of ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council. Stroke 37 (2006) 1583-1633
17. Alamowitch S., Eliasziw M., and Barnett H. The risk and benefit of endarterectomy in women with symptomatic internal carotid artery disease. Stroke 36 (2005) 27-31
18. Rothwell P., Eliasziw M., Gutnikov S., Warlow C., and Barnett H. Endarterectomy for symptomatic carotid stenosis in relation to clinical subgroups and timing of surgery. Lancet 363 (2004) 915-924
19. Ferguson G., Eliasziw M., Barr H., et al. The North American Symptomatic Carotid Endarterectomy Trial: surgical results in 1415 patients. Stroke 30 (1999) 1751-1758
20. Sabeti S., Schillinger M., Mlekusch W., et al. Contralateral high-grade carotid artery stenosis or occlusion is not associated with increased risk for poor neurologic outcome after elective carotid stent placement. Radiology 230 (2004) 70-76
21. de Nie A., Blankensteijn J., Visser G., van der G., and Eikelboom B. Cerebral blood flow in relation to contralateral carotid disease, an MRA and TCD study. Eur J VascEndovasc Surg 21 (2001) 220-226
22. Rothwell P. Treating individuals 2. Subgroup analysis in randomised controlled trials: importance, indications, and interpretation. Lancet 365 (2005) 176-186